Pharmafile Logo
Pharmafocus logo
Advanced Search

FDA green lights AstraZeneca type-2 diabetes drug

February 28, 2017
Manufacturing and Production, Sales and Marketing AstraZeneca, FDA

AstraZeneca has announced that its type-2 diabetes treatment Qtern (10mg dapagliflozin and 5mg saxagliptin) has received the approval of the …

News
jj_2johnson_and_johnson

J&J latest pharma firm to volunteer pricing data

February 28, 2017
Manufacturing and Production, Medical Communications J&J, JJ, Johnson & Johnson

Johnson & Johnson released its pricing data, as promised, in February and it has simply revealed that its average price …

News

Sanofi and Lonza partner up for €270m biologics facility

February 28, 2017
Manufacturing and Production Lonza, Sanofi

Sanofi and Lonza have announced they are to join forces in a strategic partnership which will see the establishment of …

News
14171731710_ff2df4d112_o

Huge data loss puts NHS privatisation and Health Secretary under pressure

February 28, 2017
Manufacturing and Production Jeremy Hunt, NHS, data

It has been revealed that a private company, responsible for delivering NHS data, accidentally stored 708,000 pieces of patient data …

News
janssen_latest_logo_on_sign_closer

EMA recommends expanded indication for Janssen multiple myeloma drug

February 27, 2017
Manufacturing and Production, Research and Development, Sales and Marketing Janssen, darzalex

The European Medicines Agency’s Committee for Medicinal Products for Human Use has given its positive opinion for the use of …

News
lajolla-pharmaceutical-company-ljpc-stock-news

La Jolla finds potential jewel in successful Phase 3 trial

February 27, 2017
Manufacturing and Production, Research and Development La Jolla pharmaceutical

La Jolla Pharmaceutical, a biotech company based in San Diego, US, received a boost to both its shares and its …

News
c5rxfeiwyaez8kv

Moderna Therapeutics instates MIT Treasurer to Board of Directors

February 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MIT, Moderna, Moderna Therapeutics

Moderna Therapeutics, a clinical stage biotechnology company, has announced the appointment of Israel Ruiz to the company’s Board of Directors. …

Appointment

Does Trump pose a threat to the FDA’s future?

February 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Trump

President Trump’s first month in office made headlines across the industry just as it did in the wider media. Promises …

Feature
merckincweb1

MSD’s investigational cytomegalovirus treatment shows significant promise in Phase 3 trial

February 27, 2017
Research and Development, Sales and Marketing MSD, cytomegalovirus, letermovir

MSD has lifted the curtain on strong Phase 3 results in the development of its investigational antiviral drug letermovir, showing …

News
hand

Assay opens way to autoantibodies treatment for rheumatoid arthritis

February 27, 2017
Research and Development, Sales and Marketing rheumatoid arthritis

A new discovery, conducted by researchers at the NYU Langone Medical Center and the University of Pittsburgh, has pointed towards …

News
vaccine

Cuba begins Phase 1 testing of HIV vaccine

February 27, 2017
Research and Development, Sales and Marketing Cuba, HIV

Cuba has announced that it has begun testing a HIV vaccine that looks to reduce the ‘payload’ of the virus …

News
nathalie_moll

EFPIA names first female Director General

February 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA

Industry trade organisation the European Federation of Pharmaceutical Industries and Associations (EFPIA) has announced the appointment of Nathalie Moll as …

Appointment

Weight loss drug reduces diabetes risk by 80%, according to ICL research

February 27, 2017
Research and Development, Sales and Marketing diabetes, icl, liraglutide

Researchers from Imperial College London have published research showing that use of weight loss drug liraglutide lowered the risk of …

News
celgene_1_02

Celgene announces shock departure of COO

February 27, 2017
Medical Communications, Sales and Marketing Celgene

Celgene released in a statement that its Chief Operating Officer and President, Jacqualyn “Jackie” Fouse, will retire from her position. …

News
astrazeneca-sign

AstraZeneca’s hyperkalaemia treatment rebounds with European recommendation

February 24, 2017
Sales and Marketing AstraZeneca, EMA

AstraZeneca have received some positive news on its hyperkalaemia drug, ZS-9, as it received a recommendation from the Committee for …

News
atul_pande

Ex-GSK SVP instated as CMO at PureTech

February 24, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PureTech Health

PureTech Health, a cross-disciplinary biopharmaceutical company, announced that it had appointed Atul Pande as the Chief Medical Officer. Pande had …

Appointment
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 24, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s Friday again, and this week in pharma has seen a slew of positive clinical trial results released in Crohn’s …

News
abpi_article

Developing talent and partnership to create new medicines

February 24, 2017
Medical Communications ABPI

The ABPI discusses how investing in R&D education and collaboration can reap long-term benefits to the pharmaceutical industry and the …

News
currency-166422_960_720

India’s NPPA identifies 634 non-compliant drug pricings

February 24, 2017
Medical Communications, Sales and Marketing Abbott, AstraZeneca, Cipla, Dr Reddy's, Dr Reddy’s, nppa

India’s National Pharmaceutical Pricing Authority (NPPA) has revealed that as many as 634 drugs from top pharma firms in the …

News
roche_close

Death in trial of Roche’s potential blockbuster haemophilia drug

February 24, 2017
Medical Communications, Research and Development Novo Nordisk, Roche, Shire, haemophilia

Roche has reported a death in the trial of its haemophilia treatment, emicizumab, that will only add to safety concerns …

News
The Gateway to Local Adoption Series

Latest content

Faron Pharmaceuticals appoints Heikki Jouttijärvi as Chief Technical Officer

April 2, 2026

Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London

April 1, 2026

Doccla appoints Michael Macdonnell as Chief Strategy & Growth Officer and Deputy CEO

April 1, 2026

Bramacare launches new AI platform to improve eating disorder care

March 31, 2026

Doccla appoints Jonathan Serjeant as Chief Medical Officer

March 31, 2026